No Detail Found!

Immune System Activation in Rheumatic Heart Disease.

Author(s)
Aqsa Anam Department of Immunology, University of Health Sciences (UHS), Lahore, Pakistan
Abdul Wajid Khan Faisal Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
Nadeem Afzal Department of Immunology, University of Health Sciences (UHS), Lahore, Pakistan
Faheem Shahzad Department of Immunology, University of Health Sciences (UHS), Lahore, Pakistan
Abstract
Objective: To assess activation of immune system in rheumatic heart disease (RHD) patients in the form of AECA, ACL and anti GBM antibodies. Study Design: Descriptive, observational study. Place and Duration of Study: Department of Immunology, University of Health Sciences (UHS), Lahore, and Outpatient Department, Punjab Institute of Cardiology, from February 2015 to January 2016. Methodology: Clinically suspected patients of RHD and confirmed by echocardiography were included. AECA, ACL and anti GBM antibodies were investigated in the sera of RHD patients. Results: Eighty-six RHD patients were included in the study; the mean age of the patients was 30 ±9.3 years. Among these patients, 59 (68.6%) were females and 27 (31.4%) were males. AECA was most commonly detected autoantibody i.e. in 17 (19.8%) patients; whereas, ACL was detected in only 2 (2.3%) subjects. Another 2 (2.3%) patients had both AECA and ACL antibodies. AGBM was not detected in any of the patients. ACL was seen in females with isolated MR. AECA were seen in mixed valvular heart disease patients. Conclusion: Immune system gets activated in RHD patients leading to formation of different antibodies, and they are also related to the type of lesion. ACL antibodies are present in females with isolated mitral regurgitation, while AECA are present in both the genders with mixed valvular heart disease. Anti GBM antibodies are not seen in RHD patients.
Publication Details
Page(s) 518-522
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 7, Year: 2018

Request the full text from PASTIC

References
KaplanMH,BolandeR,RakitaL,BlairJ, 1964.Presence of bound immunoglobulin and complement in the myocardium in acute rheumatic fever-association with cardiac failure,N Engl J Med 271 637 -45
MarijonE,MirabelM,CelermajerD,JouvenX, 2012.Rheumatic heart disease,Lancet 379 953 -64
CarapetisJR,StearAC,MulhollandEK,WeberM., .The global burden of group A streptococcal diseases,Lancet Infect Dis 2005 5 685 -94
AkhtarN,SadiqM,ChaganiH,HafeezA,RizviFH,MehboobM., 2004.Guidelines for prevention of rheumatic fever and rheumatic heart disease,Pak J Cardiol 136 -48
RizviSF,KhanMA,KundiA,MarshDR,SamadA,PashaA, 2004.Status of rheumatic heart disease in Pakistan,Heart 394 -9
SilwaK,CarringtonM,MayosiBM,ZigiriadisE,MvungiR,StewartS, .Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study,Eur Heart J 2010 31 719 -27
ViswanathanV, .Acute rheumatic fever,Indian J Rheumatol 2012 7 36 -43
2004.Rheumatic fever and rheumatic heart disease,Report of a WHO Expert -
GuilhermeL,FaéK,OshiroSE,KalilJ, .Molecular pathogenesis of rheumatic fever and rheumatic heart disease,Expert Rev Mol Med 1 -15
DelunardoF,ScalziV,CapozziA,CameriniS,MisasiR,PierdominiciM, 2013.Streptococcal-vimentin cross reactive antibodies induces microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease,Clin ExpImmunol 419 -29
ScalziV,HadiH,AlessandariC,CroiaC,ContiV,AgatiL, 2010.Anti-endothelial cell antibodies in rheumatic heart disease,Clin ExpImmunol 570 -5
2005.New target antigens for endothelial cell antibodies,Immunobiology 789 -97
FigueroF,BerriosX,GutierrezM,CarrionF,GoycleaJP,RiedelI, 1992.Anticardiolipin antibodies in acute rheumatic fever,J Rheumatol 1175 -80
NarinN,KutukculerN,NarinF,KeserG,DoganavsargilE., 1996.Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: is there a significant association?,Clin ExpRheumatol 567 -9
SzczechLA,AndersonA,RamersC,EngemanJ,EllisM,ButterlyD, 2006.The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease,Am J Kidney Dis 55 -9
LiCH,LiYC,XuPS,HuX,WangCY,ZouGL, 2006.Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis,Scand J Rheumatol 35 201 -8
YangR,CuiZ,HellmarkT,SegelmarkM,ZhaoMH, 2007.Natural anti-GBM antibodies from normal human sera recognize 3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease,Clinical Immunol 124 207 -12
SoeiroAM,AlmeidaMCF,AccorsiTAD,SpinaGS, 2012.Associação entre doenças imunológicas e suas manifestações clínicas semelhantes,Arquivos Brasileiros de Cardiologia 98 28 -31
CamargoEW,FreirePV, 2012.Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?,Rheumatol Int 32 1721 -5
IlarrazaH,MárquezMF,AlcocerA,BañalesJL,NavaAH,ReyesPA, 2001.Anticardiolipin antibodies are not associated with rheumatic heart disease,Lupus 10 873 -5
GunalN,BaysalK,HaciomerogluP,BeletN,KolbakirF, 2005.Rheuamtic heart disease and coronary vasculitis in children,Clin Obs 95 118 -20
GrossL,KugelMA,EpsteiEZ, 1935.Lesions of coronary arteries and their branches in rheumatic fever,Am J Pathol 253 -5
0

Citations

0

Downloads

74

Views